Logo image of COSMO.MI

FARMACOSMO SPA (COSMO.MI) Stock Fundamental Analysis

BIT:COSMO - Euronext Milan - IT0005487670 - Common Stock - Currency: EUR

0.497  -0.02 (-4.42%)

Fundamental Rating

2

Overall COSMO gets a fundamental rating of 2 out of 10. We evaluated COSMO against 55 industry peers in the Specialty Retail industry. COSMO may be in some trouble as it scores bad on both profitability and health. COSMO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

COSMO had negative earnings in the past year.
COSMO had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: COSMO reported negative net income in multiple years.
COSMO had negative operating cash flow in 4 of the past 5 years.
COSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFCOSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.63%, COSMO is doing worse than 80.00% of the companies in the same industry.
COSMO's Return On Equity of -28.08% is on the low side compared to the rest of the industry. COSMO is outperformed by 78.18% of its industry peers.
Industry RankSector Rank
ROA -9.63%
ROE -28.08%
ROIC N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
COSMO.MI Yearly ROA, ROE, ROICCOSMO.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

COSMO has a worse Gross Margin (6.61%) than 87.27% of its industry peers.
COSMO's Gross Margin has improved in the last couple of years.
COSMO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
COSMO.MI Yearly Profit, Operating, Gross MarginsCOSMO.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6

More info and screens

3

2. Health

2.1 Basic Checks

COSMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for COSMO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, COSMO has more shares outstanding
COSMO has a worse debt/assets ratio than last year.
COSMO.MI Yearly Shares OutstandingCOSMO.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
COSMO.MI Yearly Total Debt VS Total AssetsCOSMO.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

COSMO has an Altman-Z score of 2.22. This is not the best score and indicates that COSMO is in the grey zone with still only limited risk for bankruptcy at the moment.
COSMO's Altman-Z score of 2.22 is in line compared to the rest of the industry. COSMO outperforms 47.27% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that COSMO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, COSMO perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACCN/A
WACC6.88%
COSMO.MI Yearly LT Debt VS Equity VS FCFCOSMO.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

COSMO has a Current Ratio of 1.44. This is a normal value and indicates that COSMO is financially healthy and should not expect problems in meeting its short term obligations.
COSMO's Current ratio of 1.44 is fine compared to the rest of the industry. COSMO outperforms 69.09% of its industry peers.
A Quick Ratio of 0.70 indicates that COSMO may have some problems paying its short term obligations.
COSMO's Quick ratio of 0.70 is fine compared to the rest of the industry. COSMO outperforms 65.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.7
COSMO.MI Yearly Current Assets VS Current LiabilitesCOSMO.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.05% over the past year.
Looking at the last year, COSMO shows a very negative growth in Revenue. The Revenue has decreased by -11.52% in the last year.
Measured over the past years, COSMO shows a very strong growth in Revenue. The Revenue has been growing by 20.99% on average per year.
EPS 1Y (TTM)8.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.54%
Revenue 1Y (TTM)-11.52%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-11.43%

3.2 Future

Based on estimates for the next years, COSMO will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
Based on estimates for the next years, COSMO will show a quite strong growth in Revenue. The Revenue will grow by 13.48% on average per year.
EPS Next Y33.33%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
COSMO.MI Yearly Revenue VS EstimatesCOSMO.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
COSMO.MI Yearly EPS VS EstimatesCOSMO.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.02 -0.04 -0.06

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COSMO. In the last year negative earnings were reported.
Also next year COSMO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COSMO.MI Price Earnings VS Forward Price EarningsCOSMO.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, COSMO is valued a bit more expensive than 70.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 61.04
COSMO.MI Per share dataCOSMO.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

COSMO's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COSMO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FARMACOSMO SPA

BIT:COSMO (8/5/2025, 7:00:00 PM)

0.497

-0.02 (-4.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.76%
Inst Owner ChangeN/A
Ins Owners15.29%
Ins Owner ChangeN/A
Market Cap17.28M
AnalystsN/A
Price Target1.35 (171.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 1.63
P/tB N/A
EV/EBITDA 61.04
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS1.81
BVpS0.3
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.63%
ROE -28.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.61%
FCFM N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
F-Score4
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA 18.94
Cap/Depr 46.79%
Cap/Sales 1.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.7
Altman-Z 2.22
F-Score4
WACC6.88%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.54%
EPS Next Y33.33%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.52%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-11.43%
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.82%
OCF growth 3YN/A
OCF growth 5YN/A